MIRA INFORM REPORT

 

 

Report Date :

04.12.2012

 

IDENTIFICATION DETAILS

 

Name :

CAPSUGEL HEALTHCARE LIMITED (w.e.f.21.07.2006)

 

 

Formerly Known As :

BHARTI HEALTH CARE LIMITED

UNITED PHARMA INTERNATIONAL LIMITED

 

 

Registered Office :

21, Joniawas, Dharuhera, Rewari – 122100, Haryana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

13.12.1982

 

 

Com. Reg. No.:

05-020151

 

 

Capital Investment / Paid-up Capital :

Rs.1014.053 Millions

 

 

CIN No.:

[Company Identification No.]

U85110HR1982PLC020151

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

RTKB01767D

 

 

PAN No.:

[Permanent Account No.]

AAACB6447R

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Selling of Hard Gelatin Capsule Shells.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (31)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 420000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is a part of Pfizer Group. It is an established company having moderate track. Profitability of the company is under severe pressure. The company has huge accumulated losses. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered/ Sales Offices/

 Manufacturing Plant :

21, Joniawas, Dharuhera, Rewari – 122100, Haryana, India

Tel. No.:

91-1274-267092/ 93/ 97/ 99

Fax No.:

91-1274-267168

E-Mail :

pinkey.kataria@pfizer.com

narendra.batabyal@pfizer.com

darshk.pndya@pfizer.com

john.shroyer@capsugel.com

Website :

http://www.capsugel.com

 

 

DIRECTORS

 

(AS ON 30.11.2011)

 

Name :

Mr. Guido Edouard Driesen

Designation :

Director

Address :

5, Wright Lane, Far Hills, New Jersey, United States of America-07931

Date of Birth/Age :

29.11.1956

Date of Appointment :

25.09.2006

DIN No.:

00041915

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U85110HR1982PLC020151

CAPSUGEL HEALTHCARE LIMITED

Director

25/09/2006

20/12/2005

Active

NO

 

 

Name :

Ms. Siriporn Sridech

Designation :

Director

Address :

Krisadanakorn, 31, 140/6, Moo 11, Soi Rasamee 2/9, Baromrajjachonnanee Road, Thaweewattana, Bangkok-10170, Thailand

Date of Birth/Age :

08.05.1965

Date of Appointment :

20.12.2005

DIN No.:

00046061

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U85110HR1982PLC020151

CAPSUGEL HEALTHCARE LIMITED

Director

20/12/2005

20/12/2005

Active

NO

 

 

Name :

Mr. Darshak Rashmikant Pandya

Designation :

Director

Address :

Arjun Apartments, E-Wing, Flat No.401, Indraprasth Enclave N. L. Complex, Anand Nagar, Dahisar (East), Mumbai – 400068, Maharashtra, India

Date of Birth/Age :

08.02.1973

Date of Appointment :

01.08.2011

DIN No :

02967092

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U85110HR1982PLC020151

CAPSUGEL HEALTHCARE LIMITED

Whole-time director

01/08/2011

24/03/2010

Active

NO

 

 

Name :

Mr. John Shroyer

Designation :

Additional Director

Address :

8275 Kelzer Pond Drive Victoria 55386

Date of Birth/Age :

26.06.1963

Date of Appointment :

27.06.2012

DIN No :

05330783

 

 

KEY EXECUTIVES

 

Name :

Mr. Narendra Nath Batabyal

Designation :

Company Secretary

Address :

F-1/148, Mahavir Enclave, New Delhi-110045, Delhi, India

Date of Birth/Age :

14.06.1957

Date of Appointment :

11.08.2008

PAN No.:

AADPB7891F

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 23.08.2011)

 

Names of Allottee

 

 

No. of Shares Allotted

 

 

 

Capsugel Belgium BVBA, Belgium

 

9000866

 

 

 

Total

 

 

9000866

 

 

(AS ON 21.07.2011)

 

Names of Allottee

 

 

No. of Shares Allotted

 

 

 

Pfizer Pharmaceutical India Private Limited, India

 

92300000

 

 

 

Total

 

 

92300000

 

 

(AS ON 30.09.2011)

Equity Shares Break – up

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

99.76

Bodies corporate

 

0.01

Other top fifty shareholders

 

0.23

 

 

 

Total

 

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Selling of Hard Gelatin Capsule Shells.

 

 

Products :

Products Descriptions

Item Code No.

 

Hard Gelatin Capsule Shells

96020023

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

 

 

 

 

 

Capsules

No. in thousand

6,000,000

7,100,000

4,866,068

 

NOTES:

 

i) Production meant for sale is after shortages, handling losses and excludes quantity internally consumed if any.

ii) Installed capacity disclosed is on an annual basis.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of Indore

Green Park, New Delhi-110016, Delhi, India

 

·         IDBI Bank Limited

19, K. G. Marg, New Delhi, Delhi, India

 

 

Facilities :

Unsecured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

 

Other Debt Unsecured

734.455

438.956

 

 

 

Total

 

734.455

438.956

 

(A) Unsecured Loan taken from Pfizer Pharmaceutical India Private Limited (Holding Company as on 31.03.2011)

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B S R and Associates

Chartered Accountant

Address :

Building No. 10, Floor, Tower-B, DLF Cyber City, Phase-II, Gurgaon – 122002, Haryana, India

PAN No.:

AADFB6889R

 

 

Holding Company :

Pfizer Pharmaceutical India Private Limited

CIN No.: U24117MH1995FTC084206

 

 

Fellow Subsidiaries :

·         Capsugel France, France

·         Capsugel Japan Inc.(KK), Japan

·         Capsugel Belgium BVBA, Belgium

·         Suzhou Capsugel Limited, China

·         Capsugel PPK

·         Capsugel Thailand Company Limited, Thailand

·         Pfizer India Limited, India

·         PT. Capsugel, Indonesia

·         Capsugel Greenwood, USA

 

 

CAPITAL STRUCTURE

 

(AS ON 30.11.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

212000000

Equity Shares

Rs.10/- each

Rs.2120.000 Millions

1000000

Preference Shares

Rs.100/- each

Rs.100.000 Millions

 

 

 

 

 

Total

 

Rs.2220.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

202706214

Equity Shares

Rs.10/- each

Rs.2027.062 Millions

 

 

 

 

 

 

(AS ON 31.03.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

110000000

Equity Shares

Rs.10/- each

Rs.1100.000 Millions

1000000

Preference Shares

Rs.100/- each

Rs.100.000 Millions

 

 

 

 

 

Total

 

Rs.11200.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

101405348

Equity Shares

Rs.10/- each

Rs.1014.053 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

1014.053

1014.053

1014.053

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

36.334

36.334

36.334

4] (Accumulated Losses)

(945.227)

(757.021)

(618.300)

NETWORTH

105.160

293.366

432.087

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

734.455

438.956

129.948

TOTAL BORROWING

734.455

438.956

129.948

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

839.615

732.322

562.035

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

895.892

727.935

559.829

Capital work-in-progress

57.849

26.626

148.474

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

123.081
93.549

37.833

 

Sundry Debtors

93.826
58.955

40.722

 

Cash & Bank Balances

33.598
42.769

33.090

 

Other Current Assets

3.181
4.154

5.911

 

Loans & Advances

150.087
119.275

96.615

Total Current Assets

403.773
318.702

214.171

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

488.009
310.139

333.844

 

Other Current Liabilities

12.227
11.761

15.009

 

Provisions

17.663
19.041

11.689

Total Current Liabilities

517.899
340.941

360.542

Net Current Assets

(114.126)
(22.239)

(146.371)

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.103

 

 

 

 

TOTAL

839.615

732.322

562.035

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

314.308

223.034

183.228

 

 

Other Income

13.940

44.576

11.967

 

 

TOTAL                                     (A)

328.248

267.610

195.195

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption materials changes inventories

164.757

91.817

 

 

Manufacturing service costs

110.987

101.832

 

 

 

Contract cost

11.712

11.727

382.776

 

 

Employee related expenses

96.741

94.202

 

 

 

Administrative selling other expenses

34.814

38.265

 

 

 

TOTAL                                     (B)

419.011

337.843

382.776

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

(90.763)

(70.233)

(187.581)

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

50.682

23.100

4.264

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

(141.445)

(93.333)

(191.845)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

46.761

45.388

31.836

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

(188.206)

(138.721)

(223.681)

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

1.475

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

(188.206)

(138.721)

(225.156)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(757.021)

(618.300)

(393.144)

 

 

 

 

 

Add

Transitional Adjustment for Retirement Benefits

0.000

0.000

0.000

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(945.227)

(757.021)

(618.300)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

15.581

40.046

77.335

 

TOTAL EARNINGS

15.581

40.046

77.335

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

2.358

2.136

0.928

 

 

Stores & Spares

32.883

29.365

3.831

 

 

Capital Goods

159.933

11.794

149.301

 

TOTAL IMPORTS

195.174

43.295

154.060

 

 

 

 

 

 

Earnings Per Share (Rs.)

(1.86)

(1.37)

(2.32)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

(57.34)

(51.84)

(229.58)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(59.88)

(62.20)

(245.43)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(14.48)

(13.25)

(51.16)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(1.79)

(0.47)

(0.53)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

11.91

2.66

0.33

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.78

0.93

0.97

 


 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes 

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes  

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

No

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

FINANCIAL RESULTS AND OPERATIONS:

 

During the year, the Gross Total Turnover/ Sales and Other Income of the Company was Rs.354.748 millions as against Rs.282.160 millions, during the previous financial year. The Company recorded a net loss of Rs.188.206 millions against a net loss of Rs.138.721 millions during the previous financial year. The earnings per share (EPS) thus has been recorded at Rs.(1.86).

 

 

FIXED ASSETS

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixtures

·         Office Equipment

·         Computer

·         Vehicles

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.56

UK Pound

1

Rs.87.46

Euro

1

Rs.71.08

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIT

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

31

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.